文献
J-GLOBAL ID:202202225630984709
整理番号:22A0950300
2型糖尿病患者の異なる用量におけるエンパグリフロジンの有効性と安全性:ランダム化比較試験に基づくネットワークメタ分析【JST・京大機械翻訳】
Efficacy and safety of empagliflozin at different doses in patients with type 2 diabetes mellitus: A network meta-analysis based on randomized controlled trials
著者 (11件):
Wu Qian
(Department of Endocrinology, The second affiliated hospital of Nanchang University, Nanchang, China)
,
Wu Qian
(Jiangxi Medical College, Nanchang University, Nanchang, China)
,
Liu Miaowen
(Department of Endocrinology, The second affiliated hospital of Nanchang University, Nanchang, China)
,
Liu Miaowen
(Jiangxi Medical College, Nanchang University, Nanchang, China)
,
Fang Zige
(Department of Endocrinology, The second affiliated hospital of Nanchang University, Nanchang, China)
,
Fang Zige
(Jiangxi Medical College, Nanchang University, Nanchang, China)
,
Li Chenxi
(Department of Endocrinology, The second affiliated hospital of Nanchang University, Nanchang, China)
,
Li Chenxi
(Jiangxi Medical College, Nanchang University, Nanchang, China)
,
Zou Fang
(Department of Endocrinology, The second affiliated hospital of Nanchang University, Nanchang, China)
,
Hu Lei
(Department of Endocrinology, The second affiliated hospital of Nanchang University, Nanchang, China)
,
Zhang Wenxiong
(Department of Cardio-Thoracic Surgery, The second affiliated hospital of Nanchang University, Nanchang, China)
資料名:
Journal of Clinical Pharmacy and Therapeutics
(Journal of Clinical Pharmacy and Therapeutics)
巻:
47
号:
3
ページ:
270-286
発行年:
2022年
JST資料番号:
A1350A
ISSN:
0269-4727
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)